38 related articles for article (PubMed ID: 38738708)
1. Late-Stage Desulfurization Enables Rapid and Efficient Solid-Phase Synthesis of Cathepsin-Cleavable Linkers for Antibody-Drug Conjugates.
Ahangarpour M; Brimble MA; Kavianinia I
Bioconjug Chem; 2024 Jun; ():. PubMed ID: 38874557
[TBL] [Abstract][Full Text] [Related]
2. Mono-amino acid linkers enable highly potent small molecule-drug conjugates by conditional release.
Zheng Y; Xu R; Cheng H; Tai W
Mol Ther; 2024 Apr; 32(4):1048-1060. PubMed ID: 38369752
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and preclinical safety profile of legubicin: A novel conjugate of doxorubicin and a legumain-cleavable peptide linker.
Wang Y; Wei L; Liu Y; Liu C; Hou M; Zhou L; Wang L; Li H; Qiu Y; JingMa
J Appl Toxicol; 2024 May; ():. PubMed ID: 38782376
[TBL] [Abstract][Full Text] [Related]
4. Tuneable thiol exchange linkers for traceless drug release applications in prodrugs and ADCs.
Walther R; Park M; Ashman N; Welch M; Carroll JS; Spring DR
Chem Commun (Camb); 2024 Jun; ():. PubMed ID: 38888299
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-Agnostic Lysosomal Screen Identifies New Legumain-Cleavable ADC Linkers.
Miller JT; Vitro CN; Fang S; Benjamin SR; Tumey LN
Bioconjug Chem; 2021 Apr; 32(4):842-858. PubMed ID: 33788548
[TBL] [Abstract][Full Text] [Related]
6. Sulfatase-cleavable linkers for antibody-drug conjugates.
Bargh JD; Walsh SJ; Isidro-Llobet A; Omarjee S; Carroll JS; Spring DR
Chem Sci; 2020 Jan; 11(9):2375-2380. PubMed ID: 34084399
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
[TBL] [Abstract][Full Text] [Related]
8. Azobenzene-Based Linker Strategy for Selective Activation of Antibody-Drug Conjugates.
Xiao D; Liu L; Xie F; Dong J; Wang Y; Xu X; Zhong W; Deng H; Zhou X; Li S
Angew Chem Int Ed Engl; 2024 Apr; 63(16):e202310318. PubMed ID: 38369681
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin cleavable ADC linkers.
Gray ME; Zielinski KM; Xu F; Elder KK; McKay SJ; Ojo VT; Benjamin SR; Yaseen AA; Brooks TA; Tumey LN
Xenobiotica; 2024 May; ():1-13. PubMed ID: 38738708
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal-Cleavable Peptide Linkers in Antibody-Drug Conjugates.
Balamkundu S; Liu CF
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002080
[TBL] [Abstract][Full Text] [Related]
11. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
Tsuchikama K
Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
